Term
|
Definition
Mood stabilizers
Gold Standard
Treats Manic Phase
Low Therapuetic Index
|
|
|
Term
|
Definition
Nausea, Bomiting, diarrhea
Morot incoordination
Slurred Speech
Confusion
Coma
Death |
|
|
Term
|
Definition
Weight GAin
Hyperdipsia
Hyperuria
Hand Tremors |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Ratio between the toxic dose of a drug and the therapeutic dose of a drug |
|
|
Term
Depression
Biological Intervensions |
|
Definition
Medication (antidepressants)
ECT
Deep Brain STimulation
Sleep deprivation
Transcranial Magnetic Stimulation(TMS) |
|
|
Term
Transcranial Magnetic Stimulation |
|
Definition
- Antidepressant technique
- Placing a small coil of wires on the scalp and applying a brief but powerful electric current that induces a strong, localized magnetic field.
- excite the brain or inhibit neural activity
|
|
|
Term
Sleep Deprivation Therapy |
|
Definition
- Antidepressent Intervention
- Resetting the normal phase relationship between the sleep-waking cycle and the other rhythms
- Respond more quickly then using antidepressant drugs alone.
|
|
|
Term
|
Definition
- Euphorics- cocaine to treat melancholia
- Shock Treatment: insulin injection
|
|
|
Term
Monoaminergic Theory of Depression |
|
Definition
- Resperine for hypertension
- Resperine depletes monoamines- interferes with packing into synaptic vesicles
|
|
|
Term
- Reserpine
- Monoaminergic of Depression
|
|
Definition
- Monoaminergic Antagonist
- tx Hypertension
- Pts reported Depression
- decreases release of Serotonin and NE
|
|
|
Term
Antidepressants effectiveness |
|
Definition
Effective in about 66% (2/3) of depressed patients |
|
|
Term
Medication efficacy Antidepressants |
|
Definition
- changes first seen in sleep and eating patterns
- Mood improvement seen later
- Maximum efficacy seen 4-6 weeks
|
|
|
Term
Antidepressant Prescription |
|
Definition
Low abuse potential
Do NOT elevate mood in nondepressed individuals
medication maintenance- 6-8 months |
|
|
Term
- Antidepressant Medication Modalities
|
|
Definition
- Tricyclic Antidepressants (TCA)
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Monoamine Oxydase Inhibitors (MAOIs)
- Serotonin-NE Reuptake Inhibitors (SNRIs)
- Augmenters and Add-Ons
|
|
|
Term
Tricyclic Antidepressants TCAs |
|
Definition
- Inhibit Reuptake of Monoamines
- prolongs presence of NT at synaptic cleft
- primary NE agonist, secondary 5-HT agonist
- Acts of multiple systems
- Narrow Therapeutic Index
|
|
|
Term
|
Definition
- "Dirty Drugs"
- Narrow Therapeutic Index
- Serious toxicity can occur 2-6X within therapeutic range
- Death occurs with overdose of 10 Xs normal dose
- Prolongation of QT interval
|
|
|
Term
TCA side Effects
Anticholinergic |
|
Definition
- Dry mouth
- Constipation
- Urinary retention
- Blurred Vision (mydriasis- large pupil)
- Memory problems
- Confusion
|
|
|
Term
TCA side Effects
Alpha-Adrenergic |
|
Definition
- Orthostatic Hypotension
- Tachycardia
- Headache
- Nausea
|
|
|
Term
|
Definition
- Decrease in blood pressure when changing postures quickly (sitting to standing)
- Side effect of TCA's
- Alpha-Adrenergic Blockade
|
|
|
Term
TCA side effects (antidepressant)
Anti-Histaminergic |
|
Definition
- Dizziness
- Upset stomach
- Drowsiness
|
|
|
Term
Selective Serotonin Reuptake Inhibitors (SSRIs) |
|
Definition
- Serotinergic Agonist
- Antidepressant
- D/C SSRIs results in withdrawal
- safer than TCAs
|
|
|
Term
|
Definition
Drowsiness
Sleep disturbance
Nausea and vomiting
Abdominal discomfort
Weight gain
*Sexual dysfunction
*Increased suicidal ideation (children-black box warning) |
|
|
Term
|
Definition
- Fluoxetine-prozac
- Sertaline-Zoloft
- Paroxetine-Paxil
- Fluvoxamine-Luvox
- Ditalopram-Celexa
- Escitalopram-Lexapro
|
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
LUVOX
SSRI
ANTIDEPRESSANT
|
|
|
Term
|
Definition
CELEXA
SSRI
ANTIDEPRESSANT
|
|
|
Term
|
Definition
LEXAPRO
SSRI
ANTIDEPRESSANT
|
|
|
Term
|
Definition
- GAD
- Panic Disorder
- OCD
- Social Anxiety
- PTSD
- Eating Disorders
|
|
|
Term
|
Definition
|
|
Term
Serotonergic Syndrome
Autonomic |
|
Definition
- fever
- shivering
- sweating
- hyperthermia
- hypertension
- tachyccardia
- nausea
- diarrhea
|
|
|
Term
Serotinergic Syndrome
Somatic |
|
Definition
- myoclonus (motor disturbance)
- Clonus (muscular contractions and relaxation)
- Tremors
|
|
|
Term
Serotinergic Syndrome
Cognitive |
|
Definition
- agitation
- mental confusion
- hallucinations
- coma
|
|
|
Term
Serotonin Norepinephrine Reuptake
SNRIs |
|
Definition
- Antidepressant
- NE and 5-HT
- less side effects than TCAs
- more withdrawal than SSRIs
|
|
|
Term
|
Definition
- Venlafaxine (Effexor)
- Desvenlafaxine (Pristiq)
- Duloxetine (Cymbalta)
- Mirtazapine (Remeron)
|
|
|
Term
|
Definition
Effexor
SNRI
Antidepressant |
|
|
Term
|
Definition
PRISTIQ
SNRI
ANTIDEPRESSANT |
|
|
Term
|
Definition
CYMBALTA
SNRI
ANTIDEPRESSANT |
|
|
Term
|
Definition
REMERON
SNRI
ANTIDEPRESSANT |
|
|
Term
MONOAMINE OXYDASE INHIBITORS
(MAOIs) |
|
Definition
- Antidepressant
- used in atypical depression
- - atypical depression- characterized by overeating, hypersomnia
|
|
|
Term
|
Definition
- changes in blood pressure
- sleep disturbance
- overeating and weight gain
|
|
|
Term
|
Definition
- tyramine- amino acide that helps regulate blood pressure
- can't eat cheese, wine, meats, chocolate
|
|
|
Term
EFFECTS OF TYRAMINE AND MAOIs |
|
Definition
- Hypertension
- stroke
- confusion
- headaches
- heart problems
- nausea and vomiting
|
|
|
Term
|
Definition
- MAO agonist
- MAO degrades Monoamines that are in the synaptic clef
- Not contained in synaptic vesicles
|
|
|
Term
|
Definition
- Phenelzine (Nardil)
- Tranylcypromine (Parnate)
- Isocarboxzaid (Marplan)
|
|
|
Term
|
Definition
NARDIL
MAOI
ANTIDEPRESSANT |
|
|
Term
|
Definition
PARNATE
MAOI
ANTIDEPRESSANT |
|
|
Term
|
Definition
MARPLAN
MAOI
ANTIDEPRESSANT |
|
|
Term
AUGMENTER OR ADD-ON MEDS
FOR DEPRESSION |
|
Definition
- INCREASE POTENCY OF ANTIDEPRESSANTS WHEN USED IN COMBINATION
|
|
|
Term
|
Definition
- BUSPIRONE (BUSPAR)
- NEFAZODONE (SERZONE)
- TRAZODONE (DESYREL)
- QUETIAPINE FUMARATE (SEROQUEL XR)
|
|
|
Term
|
Definition
BUSPAR
AUGMENTER
ANTIDEPRESSANT |
|
|
Term
|
Definition
SERZONE
AUGMENTOR
ANTIDEPRESSANT |
|
|
Term
|
Definition
DESYREL
AUGMENTOR
ANTIDEPRESSANT |
|
|
Term
|
Definition
SEROQUEL XR
AUGMENTOR
ANTIDEPRESSANT |
|
|
Term
|
Definition
VTA (PRODUCES DOPAMINE)-->NUCLEUS ACCUMBENS-->PREFRONTAL CORTEX |
|
|
Term
|
Definition
- Electrical Self-stimulation and Substance abuse
- Direct self brain stimulation produces pleasurable sensations in pts with severe depression
|
|
|
Term
|
Definition
- DIMINISHED RESPONSE TO A DRUG AFTER REPEATED EXPOSURE TO THE DRUG.
- INCREASINGLY LARGER DOSES OF A GIVEN DRUG MUST BE ADMINISTERED TO REACH INTOXICATION OR THE DESIRED EFFECT.
|
|
|
Term
BEHAVIORAL TOLERANCE/CONTEXT-SPECIFIC TOLERANCE |
|
Definition
- tolerance manifested in same environment in which drug administered
- tolerance reduced or eliminated in novel environment
|
|
|
Term
WITHDRAWAL/
ABRUPT DISCONTINUATION SYNDROME |
|
Definition
- when drug is no longer present, neuro fx does not return to normal, it overshoots basal levels
- rebound effect
|
|
|
Term
|
Definition
- WHEN DRUG ABRUPTLY STOPS, SXS ARE MORE SEVERE
- COCAINE=SPEEDS U UP, REBOUND=CRASH
- CAN BE INDUCED BY GIVING DRUG ANTAGONIST
|
|
|
Term
Tolerance or Withdrawal
does NOT equal
Substance Dependence or Addiction |
|
Definition
Physical dependence does not necessarily lead to abuse or addiction
Cancer and chronic pain patients do not develop addiction |
|
|
Term
|
Definition
- AFTER TOLERANCE TO ONE DRUG, OTHER CHEMICALLY0RELATED DRUGS ALSO SHOW REDUCED EFFECTIVENESS
- HEROIN-->CODIENE
- SMOKING HISTORY--> LOWER SENSITIVITY TO CAFFEINE
- ALCOHOL-->BDZs
|
|
|
Term
SENSITIZATION/
REVERSE TOLERANCE |
|
Definition
- enhancement of drug effects following repeated admin of same dose of drug
- cocaine- tolerance to euphoria, sensitization motor activity
|
|
|
Term
|
Definition
- use of a substance that is chemically similar, but less addictive
- slower speed of onset
- longer duration of action
- less likelihood of high
- stimulates same brain receptors as abused drug
|
|
|
Term
|
Definition
- replacement medication blocks receptors associated with abused drug
- drug doesn't produce the same intensity of pleasurable effects
|
|
|
Term
|
Definition
- MEDICATION RESULT IN UNPLEASANT PHYSICAL SYMPTOMS IF ABUSED DRUG IS USED
- dISULFIRAM (ANTABUSE) FOR aLCOHOL
|
|
|
Term
|
Definition
- SUBSTANCE ABUSE IS ATTEMPT BY PATIENT TO SELF-MEDICATE FOR OTHER UNTREATED PSYCH PROBLEMS
- TREAT PSYCH PROBLEM DRUG ABUSE WILL BE ELIMINATED OR REDUCED
|
|
|
Term
STAGES OF PHARMACOLOGICAL TX OF SUBSTANCE ABUSE |
|
Definition
- DETOXIFICATION
- REHABILITATION
- CONTINUING/SUPPORTING CARE
|
|
|
Term
|
Definition
- Most abused
- reinforceing effects-->DA release from VTA-->NA and EOP-->Periaqueductal Gray in midbrain
|
|
|
Term
|
Definition
- Block reinforcing effects of alcohol
- Opiate antagonists
- used as an adjunt tx in alcohol abuse
|
|
|
Term
|
Definition
- sedative-hypnotic drug
- grayout and blackout- amnesia
- .15% BAC=vomiting
- .35% BAC=pass out
- .45% BAC=lethal
|
|
|
Term
|
Definition
- metabolized- 95% liver, 5% lungs
- CYTOCHROME p450 METABOLIZE ETOH
- Induction- liver enzymes increase in number with abuse ie alcohol tolerance
- Cytochrome P450 also metabolizes other drugs and will compete with alcohol to be metabolized
|
|
|
Term
|
Definition
- repeated heavy drinking produces intense withdrawal that starts within a few hours and continues over 2-4 days
- withdrawal signs can be eliminated by taking drug again or taking drug in same class (cross dependence, BNZs)
|
|
|
Term
|
Definition
- Severe form of ETOH withdrawal that involves sudden and severe mental or neuro changes
- tremors,disorientation, agitation, convulsions, hallucinations, autonomic instability
|
|
|
Term
life threatening ETOH withdrawal |
|
Definition
- alcohol detox should always be conducted medically
- 10% of patients in severe alcohol withdrawal can die w/o treatment
|
|
|
Term
|
Definition
- REPLACEMENT MEDICATION THAT ACT ON gaba RECEPTORS
- BDZs USED:
- DIAZEPAM (VALIUM)
- CLONAZEPAM (KLONOPIN)
- ALL HAVE ANTISEIZURE EFFECTS
|
|
|
Term
FDA APPROVED FOR ETOH ABUSE |
|
Definition
- NALTREXONE(ReVia)
- Disulfiram (Antabuse)
- Acamprosate (campral)
|
|
|
Term
|
Definition
- Naltrexone
- ETOH treatment
- blocks opiod receptors
- Interference treatment
|
|
|
Term
|
Definition
- Disulfiram
- ETOH treatment
- only FDA approved medication for aversion treatment of ETOH abuse
- Aversion treatment
|
|
|
Term
|
Definition
- Campral
- moste recent med approved by FDA for ETOH abuse
- stimulate GABA receptors
- reduces cravings
|
|
|